Exosomes: A potential key target in cardio-renal syndrome

Frontiers in Immunology

Volumn 5, Issue OCT, 2014, Pages

  Gonzalez Calero, Laura ^a   Martin Lorenzo, Marta ^a   Alvarez Llamas, Gloria ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Cardiovascular; Exosomes; Kidney; Proteomics

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; AQUAPORIN 1; AQUAPORIN 2; SODIUM CHLORIDE COTRANSPORTER; VOLTAGE DEPENDENT ANION CHANNEL 1;

ACUTE KIDNEY FAILURE; ATHEROSCLEROSIS; CARDIORENAL SYNDROME; CARDIOVASCULAR RISK; CELL COMMUNICATION; CHRONIC KIDNEY DISEASE; DELAYED GRAFT FUNCTION; DIABETIC NEPHROPATHY; EXOSOME; FOCAL GLOMERULOSCLEROSIS; HEART INFARCTION; HEART PROTECTION; HUMAN; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; MEMBRANE VESICLE; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; NEPHROLITHIASIS; PANCREAS ISLET BETA CELL; PROGNOSIS; SHORT SURVEY; VASCULAR SMOOTH MUSCLE;

EID: 84918769017     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00465     Document Type: Short Survey

References (41)

1. Cruz DN. Cardiorenal syndrome in critical care: the acute cardiorenal and renocardiac syndromes. Adv Chronic Kidney Dis (2013) 20:56-66. doi:10.1053/j.ackd.2012.10.005
2. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Hypertension (2003) 108:2154-69. doi:10.1161/01.CIR.0000095676.90936.80
3. Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimbürger O, Massy Z. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol (2008) 3:505-21. doi:10.2215/CJN.03670807
4. Jun M, Lv J, Perkovic V, Jardine MJ. Managing cardiovascular risk in people with chronic kidney disease: a review of the evidence from randomized controlled trials. Ther Adv Chronic Dis (2011) 2:265-78. doi:10.1177/2040622311401775
5. van der Pol E, Boing AN, Harrison P, Sturk A, Nieuwland R. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev (2012) 64:676-705. doi:10.1124/pr.112.005983
6. Hogan MC, Manganelli L, Woollard JR, Masyuk AI, Masyuk TV, Tammachote R, et al. Characterization of PKD protein-positive exosome-like vesicles. J Am Soc Nephrol (2009) 20:278-88. doi:10.1681/ASN.2008060564
7. Borges FT, Melo SA, Özdemir BC, Kato N, Revuelta I, Miller CA, et al. TGF-b1-containing exosomes from injured epithelial cells activate fibroblasts to initiate tissue regenerative responses and fibrosis. J Am Soc Nephrol (2013) 24:385-92. doi:10.1681/ASN.2012101031
8. Salih M, Zietse R, Hoorn EJ. Urinary extracellular vesicles and the kidney: biomarkers and beyond. Am J Physiol Renal Physiol (2014) 306:F1251-9. doi:10.1152/ajprenal.00128.2014
9. Prunotto M, Farina A, Lane L, Pernin A, Schifferli J, Hochstrasser DF, et al. Proteomic analysis of podocyte exosome-enriched fraction from normal human urine. J Proteomics (2013) 82:193-229. doi:10.1016/j.jprot.2013.01.012
10. Miranda KC, Bond DT, McKee M, Skog J, Paunescu TG, Da Silva N, et al. Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. Kidney Int (2010) 78:191-9. doi:10.1038/ki.2010.106
11. Zhou H, Cheruvanky A, Hu X, Matsumoto T, Hiramatsu N, Cho ME, et al. Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney Int (2008) 74:613-21. doi:10.1038/ki.2008.206
12. Moon PG, Lee JE, You S, Kim TK, Cho JH, Kim IS, et al. Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy. Proteomics (2011) 11:2459-75. doi:10.1002/pmic.201000443
13. Street JM, Birkhoff W, Menzies RI, Webb DJ, Bailey MA, Dear JW. Exosomal transmission of functional aquaporin 2 in kidney cortical collecting duct cells. J Physiol (2011) 589:6119-27. doi:10.1113/jphysiol.2011.220277
14. Anderson HC, Mulhall D, Garimella R. Role of extracellular membrane vesicles in the pathogenesis of various diseases, including cancer, renal diseases, atherosclerosis, and arthritis. Lab Invest (2010) 90:1549-57. doi:10.1038/labinvest.2010.152
15. Fleissner F, Goerzig Y, Haverich A, Thum T. Microvesicles as novel biomarkers and therapeutic targets in transplantation medicine. Am J Transplant (2012) 12:289-97. doi:10.1111/j.1600-6143.2011.03790.x
16. Borges FT, Reis LA, Schor N. Extracellular vesicles: structure, function, and potential clinical uses in renal diseases. Braz J Med Biol Res (2013) 46:824-30. doi:10.1590/1414-431X20132964
17. Alvarez S, Suazo C, Boltansky A, Ursu M, Carvajal D, Innocenti G, et al. Urinary exosomes as a source of kidney dysfunction biomarker in renal transplantation. Transplant Proc (2013) 45:3719-23. doi:10.1016/j.transproceed.2013.08.079
18. Zubiri I, Posada-Ayala M, Sanz-Maroto A, Calvo E, Martin-Lorenzo M, Gonzalez-Calero L, et al. Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis. J Proteomics (2014) 96:92-102. doi:10.1016/j.jprot.2013.10.037
19. Raimondo F, Corbetta S, Morosi L, Chinello C, Gianazza E, Castoldi G, et al. Urinary exosomes and diabetic nephropathy: a proteomic approach. Mol Biosyst (2013) 9:1139-46. doi:10.1039/c2mb25396h
20. Kalani A, Mohan A, Godbole MM, Bhatia E, Gupta A, Sharma RK, et al. Wilm's tumor-1 protein levels in urinary exosomes from diabetic patients with or without proteinuria. PLoS One (2013) 8:e60177. doi:10.1371/journal.pone.0060177
21. Zhou H, Pisitkun T, Aponte A, Yuen PS, Hoffert JD, Yasuda H, et al. Exosomal Fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury. Kidney Int (2006) 70:1847-57. doi:10.1038/sj.ki.5001874
22. Sonoda H, Yokota-Ikeda N, Oshikawa S, Kanno Y, Yoshinaga K, Uchida K, et al. Decreased abundance of urinary exosomal aquaporin-1 in renal ischemia-reperfusion injury. Am J Physiol Renal Physiol (2009) 297:F1006-16. doi:10.1152/ajprenal.00200.2009
23. van der Lubbe N, Jansen PM, Salih M, Fenton RA, van den Meiracker AH, Jan Danser AH, et al. The phosphorylated sodium chloride cotransporter in urinary exosomes is superior to prostasin as a marker for aldosteronism. Hypertension (2012) 60:741-8. doi:10.1161/HYPERTENSIONAHA.112.198135
24. Alvarez-Llamas G, de la Cuesta F, Barderas MG, Darde V, Padial LR, Vivanco F. Recent advances in aterosclerosis-based proteomics: new biomarkers and a future perspective. Expert Rev Proteomics (2008) 5:679-91. doi:10.1586/14789450.5.5.679
25. Cosme J, Liu PP, Gramolini AO. The cardiovascular exosome: current perspectives and potential. Proteomics (2013) 13:1654-9. doi:10.1002/pmic.201200441
26. Clayton A, Turkes A, Dewitt S, Steadman R, Mason MD, Hallett MB. Adhesion and signaling by B cell-derived exosomes: the role of integrins. FASEB J (2004) 18:977-9. doi:10.1096/fj.03-1094fje
27. Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood (1999) 94:3791-9.
28. Waldenstrom A, Genneback N, Hellman U, Ronquist G. Cardiomyocyte microvesicles contain DNA/RNA and convey biological messages to target cells. PLoS One (2012) 7:e34653. doi:10.1371/journal.pone.0034653
29. Sahoo S, Losordo DW. Exosomes and cardiac repair after myocardial infarction. Circ Res (2014) 114:333-44. doi:10.1161/CIRCRESAHA.114.300639
30. Yellon DM, Davidson SM. Exosomes: nanoparticles involved in cardioprotection? Circ Res (2014) 114:325-32. doi:10.1161/CIRCRESAHA.113.300636
31. Feng Y, Huang W, Wani M, Yu X, Ashraf M. Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22. PLoS One (2014) 9(2):e88685. doi:10.1371/journal.pone.0088685
32. Lai RC, Arslan F, Lee MM, Sze NS, Choo A, Chen TS, et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res (2010) 4:214-22. doi:10.1016/j.scr.2009.12.003
33. 3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Res (2013) 10:301-12. doi:10.1016/j.scr.2013.01.002
34. Chen L, Wang Y, Pan Y, Zhang L, Shen C, Qin G, et al. Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injury. Biochem Biophys Res Commun (2013) 431:566-71. doi:10.1016/j.bbrc.2013.01.015
35. Lai RC, Chen TS, Lim SK. Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regen Med (2011) 6:481-92. doi:10.2217/rme.11.35
36. Finley Austin MJ, Babiss L. Commentary: where and how could biomarkers be used in 2016. AAPS J (2006) 8:E185-9. doi:10.1208/aapsj080122
37. Zubiri I, Vivanco F, Alvarez-Llamas G. Proteomic analysis of urinary exosomes in cardiovascular and associated kidney diseases by two-dimensional electrophoresis and LC-MS/MS. Methods Mol Biol (2013) 1000:209-20. doi:10.1007/978-1-62703-405-0_16
38. Yu X, Deng L, Wang D, Li N, Chen X, Cheng X, et al. Mechanism of TNF-a autocrine effects in hypoxic cardiomyocytes: initiated by hypoxia inducible factor 1a, presented by exosomes. J Mol Cell Cardiol (2012) 53:848-57. doi:10.1016/j.yjmcc.2012.10.002
39. Kapustin A, Chatrou M, Kalra S, Drozdov I, Soong D, Furmanik M, et al. Regulated exosome secretion by vascular smooth muscle cells mediates vascular calcification. Heart (2014) 100(Suppl 3):A93-4. doi:10.1136/heartjnl-2014-306118.162
40. Zhan R, Leng X, Liu X, Wang X, Gong J, Yan L, et al. Heat shock protein 70 is secreted from endothelial cells by a non-classical pathway involvingexosomes. Biochem Biophys Res Commun (2009) 387:229-33. doi:10.1016/j.bbrc.2009.06.095
41. Giricz Z, Varga ZV, Baranyai T, Sipos P, Pálóczi K, Kittel A, et al. Cardioprotection by remote ischemic preconditioning of the rat heart is mediated by extracellular vesicles. J Mol Cell Cardiol (2014) 68:75-8. doi:10.1016/j.yjmcc.2014.01.004